Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Several Chinese institutions distanced themselves from the doctor’s claims of genetically editing babies, which can’t be verified without an independent review – yet that hasn’t stopped investors stepping back into bullish bets on the stocks exposed to potential success. (Photo: Getty)

(Bloomberg) –Gene-editing stocks traded higher after a Chinese researcher claimed to have produced the world’s first genetically edited babies.


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.